Ezetimibe-Rosuvastatin Evaluation Study

Clinical trial NCT03947866 · UNKNOWN

Trial details

NCT number: NCT03947866
Sponsor: Elpen Pharmaceutical Co. Inc.
Status: UNKNOWN
Study type: OBSERVATIONAL

Hypercholesterolemia Hyperlipidemias Combinations of Drugs; Dependence

Start date: 2022-09-30
Primary completion: 2023-09-30
Enrollment: 600

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.